This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Other. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Samira Khaldi-Plassart: Innovator in Biologics Preservation
Introduction
Samira Khaldi-Plassart is a prominent inventor based in Dijon, France. She has made significant contributions to the fields of immunology and vaccine technology. Her innovative work focuses on methods for freeze-drying and rehydrating biological preparations, which are crucial for preserving the viability of various biological materials.
Latest Patents
Samira holds a patent titled "Methods for freeze-drying and rehydrating biologics." This invention relates to techniques for freeze-drying biological preparations, including peptides, antigens, antibodies, and cells. The methods she developed are particularly effective in preserving the viability, infectivity, and immunogenicity of cells from the Apicomplexa phylum, specifically from the Sarcocystidae family.
Career Highlights
Throughout her career, Samira has demonstrated a strong commitment to advancing the field of immunology. Her innovative approaches have garnered attention and recognition within the scientific community. She has successfully navigated the complexities of biological preservation, contributing to the development of more effective vaccines and immunological treatments.
Collaborations
Samira has collaborated with notable colleagues, including Noel Yves Henri Jean Genin and Jean-Christophe Francis Audonnet. These partnerships have further enhanced her research and development efforts, leading to advancements in the preservation of biologics.
Conclusion
Samira Khaldi-Plassart is a trailblazer in the field of biologics preservation, with her patent reflecting her dedication to improving immunological technologies. Her work continues to impact the scientific community positively, paving the way for future innovations in vaccine technology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile